Skip to main navigation Skip to search Skip to main content

Supraorbital nerve stimulation

  • Christopher L. Robinson
  • , Cyrus Yazdi
  • , Thomas T. Simopoulos
  • , Alan David Kaye
  • , Ivan Urits
  • , Jamal J. Hasoon
  • , Vwaire Orhurhu
  • , Sait Ashina
  • , Moises Dominguez

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

The eTNS is placed in the middle of the forehead of the patient, and transcutaneous electrical stimulation is applied to the supraorbital and supratrochlear nerves, terminal branches of the trigeminal nerve ophthalmic division. Given the limited side effects of this noninvasive device for episodic migraine prevention and acute treatment of migraine with and without aura, the use of eTNS is overall a safe therapy for most patients but is contraindicated in patients with other implanted electrical devices such as pacemakers.

Original languageEnglish
Title of host publicationInterventional Management of Migraines and Other Headache Disorders
PublisherElsevier
Pages131-143
Number of pages13
ISBN (Electronic)9780443235573
ISBN (Print)9780443235580
DOIs
StatePublished - 1 Jan 2024
Externally publishedYes

Keywords

  • Clinical neurophysiology
  • Nervous system
  • Nervous system disorder
  • Neurologic finding
  • Neurophysiology

Fingerprint

Dive into the research topics of 'Supraorbital nerve stimulation'. Together they form a unique fingerprint.

Cite this